Navigation Links
Transplant in Biological Technology

Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients

... meeting today indicates that monitoring cardiac transplant patients with the Urine NGAL assay on Abbott's ... at the University of Toronto, eleven heart transplant patients were treated with anti-rejection drug ... toxicity in the kidneys following heart transplant procedures. Abbott is currently ...

Serial Monitoring With ImmuKnow(R) is Useful in the Risk Assessment of Kidney Transplant Recipients

... this study will be presented during the American transplant Congress in Boston, MA May 30 - June 3, 2009 ... in determining rejection or infection in kidney transplant recipients. Patients were randomly selected after ... tool for helping clinicians manage their transplant patients," added Dr. Phillip Ruiz, author and ...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

... for the prevention of organ rejection in kidney transplant recipients. Prograf is a cornerstone therapy for preventing transplant rejection in liver, kidney and heart transplant recipients. The approval came on May 19, 2009 in ...

Chad Ronholdt Joins LABS Inc.

... 29 /PRNewswire/ -- LABS Inc., one of the premier transplant reference and consultative laboratories in the ... forward." LABS Inc. has been serving the transplant community for more than 25 years in the areas of ... About LABS Inc. LABS Inc. is a premier transplant medicine reference laboratory bringing ...

American Transplant Congress 2009

... 23 /PRNewswire/ -- The ninth annual American transplant Congress 2009 (ATC) is the premier educational ... meeting, sponsored by the American Society of transplant Surgeons (ASTS) and the American Society of ... more information about the American Society of transplant Surgeons, visit www.asts.org . Learn more about ...

Transplant Program Tops in Expected One-Year Survival Rate

... Hutchinson Cancer Research Center's stem-cell transplant program at the Seattle Cancer Care Alliance (SCCA) was one of only two transplant programs nationwide that consistently ... an independent report that assessed 122 transplant centers over a five-year period. The ...

Study Shows Machine Perfusion Significantly Improves Transplant Results

... machine perfusion can play in improving kidney transplant outcomes," said David Kravitz, Chief Executive ... that the odds of a delay in kidney function post transplant were reduced by almost half when machine ... the number of those waiting for a life-saving transplant has passed 100,000," said Joseph Vassalotti, MD, ...

Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice

... in turn will put pressure on the already long transplant waiting lists.(3,4) "This is a truly important finding for the thousands of people on transplant waiting lists around the world", said Rutger ... investigator for the trial and Professor of transplant Surgery at the University Medical Center ...

AlloSource, Tissue Recipient Join 'Stars of Life' Affected by Organ and Tissue Donation Aboard Donate Life Float in 2009 Rose Parade(R)

... including living donors, donor families, transplant recipients and transplant candidates. The AlloSource-sponsored float ... of Life" float with 25 other riders including transplant recipients, living donors, and family members of ...

Hawaii LASIK Eye Surgery Expert Dr. John D. Olkowski Qualifies and Lists with Trusted LASIK Surgeons

... IntraLase Enabled Keratoplasty, a form of corneal transplant surgery that underscores his surgical skills in ... Enabled Keratoplasty in Hawaii, a form of corneal transplant surgery that underscores his expert surgical ... care needs, including LASIK, Cataract and Corneal transplant Surgeries. The Medical Director and Chief ...

"Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart

... only options were to receive an immediate heart transplant or, if a matching donor heart couldn't be found, ... diet and exercise helped make him a healthier transplant candidate. "Before I got transplanted, ... is currently approved as a bridge to human heart transplant for patients dying from end stage biventricular ...

AST Endorses Istanbul Declaration to End Organ Trafficking and Transplant Tourism

... Declaration of Istanbul on Organ Trafficking and transplant Tourism. The Declaration of Istanbul affirms ... Dr. Harmon attended the International Summit on transplant Tourism and Organ Trafficking in May as the AST's ... About AST The AST is an organization of transplant professionals dedicated to research, education, ...

NxStage Announces Access to Demographic and Outcomes Information for the Growing U.S. Daily Home Hemodialysis Patient Population

... includes correlation with survival and kidney transplant relative to that observed with conventional ... ), include the following: -- Survival and transplant rates are notably higher among the ... addressed. In compiling the survival and kidney transplant analysis, NxStage captured mortality data from ...

Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants

... One of the major risks of an allogeneic transplant (one that uses stem cells removed from a donor) ... whether the theoretical manipulation of a transplant by removing donor T cells that might launch ... research will enable us to predict before the transplant what kind of a response we would get in a patient ...

Genzyme Files Applications for Approval of Mozobil in the United States and Europe

... a process that destroys bone marrow. A stem cell transplant is required to replenish blood-forming bone ... a healthy person needs. Currently, before a transplant can take place, patients may receive a prescribed ... for a transplant. In order for the transplant to take place, a minimum number of approximately ...

Genzyme Reports Strong First-Quarter Growth

... kidney disease indications. -- Within the transplant business, first-quarter sales of Thymoglobulin(R) ... peak annual sales of the product in the transplant setting of $400 million. Mozobil is an ... and predictably prepare cancer patients for a transplant to treat their disease. Genzyme is also ...

JCI table of contents: April 22, 2008

... by transplantation with islet cells. However, transplant recipients must be treated with a drug regimen, ... leading them to suggest that this contributes to transplant failure. In the study, the T cell loss caused ... protein (GAD65) expressed by islet cells. In two transplant recipients studied, two of the drugs in the ...

Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection

... to closely reflect the immune function of the transplant recipient and patient risk for organ rejection ... studied the immune function of 76 adult heart transplant patients. A total of 170 ImmuKnow assays were ... "Immune function monitoring of adult heart transplant patients using the ImmuKnow assay may have the ...

LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007

... approximately 80 hospitals, including five organ transplant centers in its service area, to facilitate ... die each week waiting for a life-saving organ transplant that doesn't come in time. Virginians can sign up ... thousands of people who are waiting for an organ transplant or a life-enhancing tissue transplant." Organs ...

New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection

... patients that may be at risk for early acute transplant rejection and unstable kidney function in the ... which was authored by members of the kidney transplant programs at Duke University Medical Center ... or associations." This study of 126 kidney transplant patients was designed to evaluate the association ...

CryoLife Responds to Inaccurate Assertions from Plaintiff's Attorney

... who contracted an infection following a transplant of a meniscal allograft in December 2006. ... several previous knee operations. A meniscal transplant is often recommended as the last resort before total knee replacement surgery. When a meniscal transplant is contemplated, it is routine medical procedure ...

Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program

... program offers unique resources to empower transplant patients and their ... field of transplantation, and The International transplant Nurses Society (ITNS), a leading ... further materials for the multi-award-winning transplant Experience program -- a comprehensive, ...

Breakthrough research identifies how cells from pigs may cure diabetes

... sections of the Transplantation Society the Cell transplant Society (CTS), the International Pancreas and Islet transplant Association (IPITA) and the International ... issues, researchers are now working to transplant porcine islets in an engineered pre-vascularized, ...

Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma

... staves. Together, we hope to demonstrate the advantage of the StemEx transplant for patients," said Dr. David Snyder, vice president of clinical ... patients with blood cancers in an international pivotal trial at leading transplant centers in the U.S., Europe and Israel. StemEx has orphan drug designation ...

Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations

... No immune suppressants were used, which is in contrast to conventional transplant procedures. Nevertheless, no cases of severe grade III/IV acute GvHD ... patients in the higher dose cohorts show high survival rates (75%) with no transplant related mortality (TRM). These results show that the selective ...

Gen-Probe Completes Acquisition of Tepnel Life Sciences

... - Transaction Brings Growth Opportunities in transplant Diagnostics, Genetic Testing and Pharmaceutical Services, Accelerates ... "We believe this acquisition brings Gen-Probe new growth opportunities in transplant diagnostics, genetic testing and pharmaceutical services, and also ...

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

... patient who had both HIV infection and leukemia and received a bone marrow transplant from a donor carrying the CCR5 mutation. After the successful bone marrow ... by naturally occurring mutations in man and the recent bone marrow transplant report," commented Dale Ando, M.D., Sangamo's vice president of ...

Don't Wait - Do It Now!(TM) Become an Organ and Tissue Donor

... daily. In Ohio, nearly 3,000 people are waiting for a life saving organ transplant and many more are in need of tissue. Four Ohioans die each week waiting ... the Ohio Department of Public Safety and the Minority Organ and Tissue transplant Education Program. About Second Chance Trust Fund Through ...

Rigel Announces Third Quarter 2008 Financial Results and Clinical Update

... Rigel will move forward with another selective Jak3 inhibitor compound for transplant rejection. Rigel expects to select this new Jak3 inhibitor compound by the end of 2008. Rigel will proceed on its own with this compound in transplant rejection. Rigel does not plan to start a second rheumatoid arthritis ...

Five New Clinical Studies Show Value of Masimo PVI & PI

... of Pleth Variability Index to Detect Preload Changes in Orthotopic Liver transplant Patients(3)-A1605, Presented: October 22, 2008, 8:00-9:30 a.m., Room 230C ... of Pleth Variability Index to Detect Preload Changes in Orthotopic Liver transplant Patients. Christopher Wray, M.D., Jack Buckley, M.D., Derek Kwan, B.S., ...

CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team

... pioneering physician who performed the world's first successful cord blood transplant (sibling donor) in 1988. In fact, leaders from the international cord ... Cord Blood Bank at Duke. She performed the first successful cord blood transplant from an unrelated donor in 1993 and has since performed 900 umbilical cord ...

Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.

... John Theurer Cancer Center each year to undergo a life-saving stem cell transplant at the program. Last year, the program reported outcomes success rates of ... and societies, including the Center for International Blood and Marrow transplant Research and the Foundation for the Accreditation of Cellular Therapy. In ...

Highlights of Economic and Business Growth in the Tampa Bay Region

... Ground on Tampa Bay Ocular Research Center The Lions Eye Institute for transplant & Research broke ground recently on a 12,000-square-foot ocular research ... will allow the institute to provide more corneal transplants. Its transplant and research development facility procures, prepares and distributes human ...

Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc

... transplants for patients with end stage blood cancer. An autologous transplant uses the patient's own bone marrow to serve as a graft. Bone-marrow ... treatment. This is often caused by the presence of cancer cells in the transplant and the fact that the patients' own white blood cells does not fight the ...

JCI table of contents: Dec. 3, 2007

... warranty on your new lung: Artery reattachment may be the key to long-term transplant survival Small-airway fibrosis, the chronic scarring and subsequent ... Alto Health Care System. Lung transplantation is the only same-species transplant surgery not followed by reconnection of the arteries, a process known as ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... Cancer Research Center. The second trial was a 129-patient pivotal Phase 3 multi-center clinical trial conducted at 16 leading bone marrow/stem cell transplant centers in the United States and France. Although orBec(R) did not achieve statistical significance in the primary endpoint of its pivotal trial, ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... these observations suggest that a metabolite of oral BDP may be having a beneficial anti-inflammatory effect in the lungs of hematopoietic cell transplant recipients," stated Jason W. Chien, MD, MS, Assistant Member, Clinical Research Division of the Fred Hutchinson Cancer Research Center. "There was ...

Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue

... Organovo, Inc. is a seed-stage regenerative medicine company that applies proprietary organ printing technology to solve critical problems in transplant medicine, cardiovascular medicine, tissue repair, and medical research. Organovo aims to solve complex medical problems with one overarching goal: to ...

RSCI Announces World-Leading Stem Cell Science Advisory Board

... olfactory stem cells harvested from the patient's own nose, Dr. Lima transplants the cells at the spinal cord break utilizing the successful OMA transplant surgical procedure he developed. He was the first doctor in the world whose treatments, coupled with extensive rehabilitation therapy, created the ...

Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing

... Proceeds will support the advancement of Opsona's clinical trials targeting inflammatory diseases such as rheumatoid arthritis, lupus and solid organ transplant rejection. It will also be used to improve Opsona's capability to clinically evaluate novel compounds for in-licensing aimed at treating autoimmune ...
Other Contents
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare Suite, ... devices, has cut emergency room wait times by an ... (UCSD) Medical Center, according to a recent study published ... Departments are using the suite to access data from ... defibrillators. "Using Geneva,s technology platform we have ...
(Date:7/24/2014)... for food or commercial food sale, has been heavily ... of many species of primates and other mammals. ... of the species being consumed are birds, particularly large ... the meat made available for sale but the meat ... and brought to villages for consumption, we noted a ...
(Date:7/24/2014)... different effects on different species of fish, according ... Bristol and Exeter which tested fish anti-predator behaviour. ... flying seagull predator model when exposed to additional ... minnows. , Lead author Dr Irene Voellmy ... levels in many aquatic environments have increased substantially ...
Breaking Biology News(10 mins):UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
(Date:7/25/2014)... be treated more quickly after Manchester research , ... blood test on arrival, is effective in reducing ... study shows., The findings of a research group ... could potentially make a huge difference to a ... most common reason for emergency hospital admission. In ...
(Date:7/25/2014)... some patients is real and is only natural. However, ... in Cancer , the incidence and effects of ... computed tomography (CT) lung cancer screening exams are far ... , "Unsubstantiated claims of systemic and harmful patient ... continue to delay implementation of CT lung cancer screening ...
(Date:7/25/2014)... Ross A. Clevens, MD, FACS, and ... join the exclusive Obagi Clinical Advisory Board, comprised of ... plastic surgeons and dermatologists. , Dr. Clevens recently ... of thought leaders held its first meeting in three ... give Obagi the opportunity to meet with eight of ...
(Date:7/25/2014)... A report released by the Juvenile Diabetes ... 2013 (July 1, 2012- June 30, 2013). , Outside of ... is the largest single funder of type 1 diabetes research ... with most of the top research centers. There is ... 1 diabetes in the near future. , Since the 2008 ...
(Date:7/25/2014)... HealthDay Reporter , THURSDAY, July ... girls and boys are getting the human papillomavirus (HPV) vaccine, ... officials said Thursday. The U.S. Centers for Disease Control ... 12 get the three-dose vaccine so that protection is in ... Yet, despite a slight increase over the year before, only ...
Breaking Medicine News(10 mins):Health News:Heart attack patients could be treated more quickly after Manchester research 2Health News:ACR statement on cancer study regarding patient anxiety from CT lung cancer screening 2Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2Health News:Report: JDRF 2013 Annual Research Spending Down by $50 million 2Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3
Other TagsOther Tags